Why the study?
Recent randomized trials showed an increased periprocedural stroke risk in elderly patients undergoing CAS, prompting evaluation of a tailored-CAS approach in patients over 80 years old.
Does a tailored carotid artery stenting strategy result in comparable periprocedural safety outcomes in patients ≥80 years old compared to those <80 years old?
Does a tailored carotid artery stenting strategy result in comparable periprocedural safety outcomes in patients ≥80 years old compared to those <80 years old?
Answers are grounded in this paper and cite their sources.
A tailored carotid artery stenting strategy based on lesion morphology and plaque characteristics yields comparable 30-day safety outcomes in octogenarians and younger patients.
Purpose: Carotid artery stenting (CAS) reduces the risk of ischemic stroke in patients with carotid artery stenosis, although recent randomized trials showed an increase in periprocedural stroke risk in elderly patients undergoing CAS. Recently, the safety and efficacy of tailored-CAS was reported. We retrospectively compared the clinical results of tailored-CAS between patients >80 and <80 years old.
No takes yet. Share an insight, caveat, or question.
Nishiyama et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: